Tim Serno
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Protein purification and stability 9
- Viral Infectious Diseases and Gene Expression in Insects 3
- Glycosylation and Glycoproteins Research 1
-
- Drug Solubulity and Delivery Systems 2
- Advanced Drug Delivery Systems 1
- Co-authors
- Gerhard Winter (3 shared papers)Raimund Geidobler (1 shared paper)Theodore W. Randolph (1 shared paper)John F. Carpenter (1 shared paper)Achim Goepferich (2 shared papers)Oliver Germershaus (2 shared papers)Elisabeth Härtl (1 shared paper)R. Miller (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Journal of Controlled Release (1 paper)Pharmaceutical Research (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Tim Serno
9 papers receiving 399 citations
Peers
Comparison fields: 5 of 71
- Pharmaceutical Science 111
- Radiology, Nuclear Medicine and Imaging 120
- Molecular Biology 302
- Biomaterials 44
- Food Science 48
Countries citing papers authored by Tim Serno
This map shows the geographic impact of Tim Serno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Serno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Serno more than expected).
Fields of papers citing papers by Tim Serno
This network shows the impact of papers produced by Tim Serno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Serno. The network helps show where Tim Serno may publish in the future.
Co-authors
The 21 scholars most cited alongside Tim Serno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 153 | |
| 2 | 2009 | 102 | |
| 3 | 2014 | 43 | |
| 4 | 2012 | 42 | |
| 5 | 2013 | 29 | |
| 6 | 2013 | 22 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 3 |
About Tim Serno
Tim Serno is a scholar working on Molecular Biology, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 9 papers that have together received 412 indexed citations. Recurring topics across this work include Protein purification and stability (9 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Drug Solubulity and Delivery Systems (2 papers), Biosimilars and Bioanalytical Methods (1 paper), Advanced Drug Delivery Systems (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Analytical Chemistry and Chromatography (1 paper). The work is most often cited by research in Pharmaceutical Science (111 citations), Radiology, Nuclear Medicine and Imaging (120 citations), Molecular Biology (302 citations), Biomaterials (44 citations) and Food Science (48 citations). Tim Serno has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Gerhard Winter, Raimund Geidobler, Theodore W. Randolph, John F. Carpenter, Achim Goepferich, Oliver Germershaus, Elisabeth Härtl, R. Miller, Ahmed Besheer and Michael Jahn. Their work appears in journals such as Journal of Pharmaceutical Sciences, Journal of Controlled Release, Pharmaceutical Research, European Journal of Pharmaceutics and Biopharmaceutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.